ArticleBMJ open2026

Adjuvant mecobalamin for anti-VEGF therapy in retinal vein occlusion: protocol of a single-centre, randomised, double-blinded controlled trial.

Ke-Yu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.